Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study JSM Peiris, CM Chu, VCC Cheng, KS Chan, IFN Hung, LLM Poon, KI Law, ... The lancet 361 (9371), 1767-1772, 2003 | 3121 | 2003 |
Human infection with influenza H9N2 M Peiris, KY Yuen, CW Leung, KH Chan, PLS Ip, RWM Lai, WK Orr, ... The Lancet 354 (9182), 916-917, 1999 | 1449 | 1999 |
Viral loads and duration of viral shedding in adult patients hospitalized with influenza N Lee, PKS Chan, DSC Hui, TH Rainer, E Wong, KW Choi, GCY Lui, ... The Journal of infectious diseases 200 (4), 492-500, 2009 | 645 | 2009 |
Curcumin (diferuloylmethane) inhibits constitutive NF-¥êB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma S Shishodia, HM Amin, R Lai, BB Aggarwal Biochemical pharmacology 70 (5), 700-713, 2005 | 627 | 2005 |
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer JJ Farrell, H Elsaleh, M Garcia, R Lai, A Ammar, WF Regine, R Abrams, ... Gastroenterology 136 (1), 187-195, 2009 | 520 | 2009 |
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma J Spratlin, R Sangha, D Glubrecht, L Dabbagh, JD Young, C Dumontet, ... Clinical Cancer Research 10 (20), 6956-6961, 2004 | 518 | 2004 |
Class III ¥â-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel P Seve, J Mackey, S Isaac, O Tredan, PJ Souquet, M Perol, R Lai, ... Molecular Cancer Therapeutics 4 (12), 2001-2007, 2005 | 349 | 2005 |
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic ¡¦ R Marechal, JR Mackey, R Lai, P Demetter, M Peeters, M Polus, CE Cass, ... Clinical cancer research 15 (8), 2913-2919, 2009 | 325 | 2009 |
Pathobiology of ALK+ anaplastic large-cell lymphoma HM Amin, R Lai Blood, The Journal of the American Society of Hematology 110 (7), 2259-2267, 2007 | 308 | 2007 |
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice Y Ma, W Cui, J Yang, J Qu, C Di, HM Amin, R Lai, J Ritz, DS Krause, ... Blood 108 (8), 2726-2735, 2006 | 284 | 2006 |
Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells Q Lin, R Lai, LR Chirieac, C Li, VA Thomazy, I Grammatikakis, ... The American journal of pathology 167 (4), 969-980, 2005 | 282 | 2005 |
Outcomes of adults hospitalised with severe influenza N Lee, KW Choi, PKS Chan, DSC Hui, GCY Lui, BCK Wong, RYK Wong, ... Thorax 65 (6), 510-515, 2010 | 274 | 2010 |
Cryptococcosis in apparently immunocompetent patients G Lui, N Lee, M Ip, KW Choi, YK Tso, E Lam, S Chau, R Lai, CS Cockram Journal of the Association of Physicians 99 (3), 143-151, 2006 | 273 | 2006 |
Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma EJ Schlette, LJ Medeiros, A Goy, R Lai, GZ Rassidakis Journal of clinical oncology 22 (9), 1682-1688, 2004 | 271 | 2004 |
Micelles of poly(ethylene oxide)‐b‐poly(¥å‐caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin Z Ma, A Haddadi, O Molavi, A Lavasanifar, R Lai, J Samuel Journal of Biomedical Materials Research Part A: An Official Journal of The ¡¦, 2008 | 252 | 2008 |
Fecal viral load and norovirus-associated gastroenteritis MCW Chan, JJY Sung, RKY Lam, PKS Chan, NLS Lee, RWM Lai, ... Emerging infectious diseases 12 (8), 1278, 2006 | 242 | 2006 |
Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma HM Amin, TJ McDonnell, Y Ma, Q Lin, Y Fujio, K Kunisada, V Leventaki, ... Oncogene 23 (32), 5426-5434, 2004 | 237 | 2004 |
Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells M Han, MR Vakili, H Soleymani Abyaneh, O Molavi, R Lai, A Lavasanifar Molecular pharmaceutics 11 (8), 2640-2649, 2014 | 234 | 2014 |
The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin XB Xiong, Z Ma, R Lai, A Lavasanifar Biomaterials 31 (4), 757-768, 2010 | 226 | 2010 |
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype WH Wilson, SH Jung, P Porcu, D Hurd, J Johnson, SE Martin, ... haematologica 97 (5), 758, 2012 | 225 | 2012 |